RVPH (Reviva Pharmaceuticals Holdings) OCF Yield %: -226.65 (As of Jun. 29, 2026)


RVPH Reviva Pharmaceuticals Holdings Inc RVPH
26 GF Score
Price $0.68
! 1 Warning Sign
View Full Analysis

What is Reviva Pharmaceuticals Holdings OCF Yield %?

Reviva Pharmaceuticals Holdings RVPH +1.37% 26 OCF Yield % is -226.65 as of Jun. 29, 2026. GuruFocus rates RVPH with a GF Score™ of 26/100. The stock has 1 warning sign investors should review. Among 1,416 Biotechnology companies, Reviva Pharmaceuticals Holdings ranks worse than 95.9% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Reviva Pharmaceuticals Holdings's Trailing 12-Month Cash Flow from Operations is $-20.20 Mil, and Market Cap is $8.91 Mil. Therefore, Reviva Pharmaceuticals Holdings's OCF Yield % for today is -226.65%.

The historical rank and industry rank for Reviva Pharmaceuticals Holdings's OCF Yield % or its related term are showing as below:

RVPH' s OCF Yield % Range Over the Past 10 Years
Min: -248.54   Med: 0   Max: -226.62
Current: -226.65


During the past 7 years, the highest OCF Yield % of Reviva Pharmaceuticals Holdings was -226.62%. The lowest was -248.54%. And the median was %.

RVPH's OCF Yield % is ranked worse than
95.9% of 1416 companies
in the Biotechnology industry
Industry Median: -8.23 vs RVPH: -226.65

Reviva Pharmaceuticals Holdings's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Reviva Pharmaceuticals Holdings OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Reviva Pharmaceuticals Holdings OCF Yield % Related Terms


Reviva Pharmaceuticals Holdings OCF Yield % Historical Data

* Premium members only.

The historical data trend for Reviva Pharmaceuticals Holdings's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Reviva Pharmaceuticals Holdings OCF Yield % Chart

Reviva Pharmaceuticals Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial -25.56 -21.83 -19.70 -39.79 -75.05

Reviva Pharmaceuticals Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -73.52 -77.38 -62.96 -70.77 -162.65

RVPH vs AIM, BOLT, BRTX: OCF Yield % Comparison

For the Biotechnology subindustry, Reviva Pharmaceuticals Holdings's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Reviva Pharmaceuticals Holdings OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Reviva Pharmaceuticals Holdings's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Reviva Pharmaceuticals Holdings's OCF Yield % falls into.


RVPH
26GF Score
Reviva Pharmaceuticals Holdings Inc RVPH
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Reviva Pharmaceuticals Holdings OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Reviva Pharmaceuticals Holdings's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-24.595 / 32.77134
=-75.05%

Reviva Pharmaceuticals Holdings's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-3.801 * 4 / 9.347457
=-162.65%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -226.65 mean?
Reviva Pharmaceuticals Holdings (RVPH) has a OCF Yield % of -226.65 as of Jun. 29, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Reviva Pharmaceuticals Holdings and its competitors. According to the industry distribution chart, Reviva Pharmaceuticals Holdings ranks #1358 out of 1416 companies in the Biotechnology industry, placing it in the top 95.9%.
Is Reviva Pharmaceuticals Holdings' OCF Yield % too high?
Reviva Pharmaceuticals Holdings' current OCF Yield % is -226.65. Based on the distribution chart, Reviva Pharmaceuticals Holdings ranks #1358 out of 1416 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Reviva Pharmaceuticals Holdings has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Reviva Pharmaceuticals Holdings' OCF Yield % compare to AIM and BOLT?
According to the Biotechnology industry distribution chart, Reviva Pharmaceuticals Holdings ranks #1358 out of 1416 companies for OCF Yield %. This places Reviva Pharmaceuticals Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Reviva Pharmaceuticals Holdings and its competitors. Reviva Pharmaceuticals Holdings's current OCF Yield % is -226.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reviva Pharmaceuticals Holdings stock overvalued right now?
Reviva Pharmaceuticals Holdings (RVPH) has a current OCF Yield % of -226.65. The current OCF Yield % is -226.65. Reviva Pharmaceuticals Holdings' overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Reviva Pharmaceuticals Holdings (RVPH), the current OCF Yield % is -226.65 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Reviva Pharmaceuticals Holdings Business Description

Address 10080 North Wolfe Road, Suite SW3-200, Cupertino, CA, USA, 95014
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063), which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis, and its other drug candidate is RP1208.
26GF Score

Get the complete analysis for RVPH

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.68
Price